Table 4 Description of pharmaceutical knowledge about OTC drug safety during pregnancy
Drug | Safe | Must evaluate risk/benefit | Not safe | I don’t know |
|---|---|---|---|---|
Frequency (%) | ||||
Paracetamol | 203 (98.1) | 4 (1.9) | 0 (0.0) | 0 (0.0) |
Ibuprofen | 37 (17.9) | 84 (40.6) | 85 (41.1) | 1 (0.5) |
Guaifenesin | 82 (39.6) | 89 (43.0) | 31 (15.0) | 5 (2.4) |
Pseudoephedrine | 30 (14.5) | 74 (35.7) | 91 (44.0) | 12 (5.8) |
Aspirin | 121 (58.5) | 76 (36.7) | 8 (3.9) | 2 (1.0) |
Caffeine | 80 (38.6) | 89 (43.0) | 29 (14.0) | 9 (4.3) |
Famotidine | 184 (88.9) | 17 (8.2) | 6 (2.9) | 0 (0.0) |
Dextromethorphan | 65 (31.4) | 95 (45.9) | 39 (18.8) | 8 (3.9) |
Fluticasone Nasal | 101 (48.8) | 72 (34.8) | 22 (10.6) | 12 (5.8) |
Loratadine | 144 (69.6) | 42 (20.3) | 13 (6.3) | 8 (3.9) |
Rectal Lidocaine | 60 (29.0) | 72 (34.8) | 41 (19.8) | 34 (16.4) |
Bismuth subsalicylate | 32 (15.5) | 77 (37.2) | 59 (28.5) | 39 (18.8) |
Omeprazole | 120 (58.0) | 60 (29.0) | 25 (12.1) | 2 (1.0) |
Calcium Carbonate | 189 (91.3) | 13 (6.3) | 2 (1.0) | 3 (1.4) |
Ferrous gluconate | 195 (94.2) | 9 (4.3) | 0 (0.0) | 3 (1.4) |
Folic acid | 206 (99.5) | 1 (0.5) | 0 (0.0) | 0 (0.0) |
Magnesium sulfate | 142 (68.6) | 43 (20.8) | 10 (4.8) | 12 (5.8) |
Potassium chloride | 94 (45.4) | 69 (33.3) | 13 (6.3) | 31 (15.0) |